Osteoprotegerin is independently associated with metabolic syndrome and microvascular complications in type 2 diabetes mellitus

Conclusion:
Higher OPG levels were associated with risk of MS and microvascular complications. Studies are needed to test whether OPG could be a useful biomarker identifying patients at risk of vascular complications and whether further exploration of this pathway may lead novel therapeutic options.

Source: Diabetes and Vascular Disease Research - August 12, 2014 Category: Endocrinology Authors: Tavintharan, S., Pek, L. T. S., Liu, J. J., Ng, X. W., Yeoh, L. Y., Su Chi, L., Chee Fang, S. Tags: Brief Report Source Type: research